Sarah Kim

Sarah Kim, Ph.D.

Research Assistant Professor

Department: Pharmaceutics
Business Phone: (407) 313-7044
Business Email: sarahkim@cop.ufl.edu

About Sarah Kim

Sarah Kim, Ph.D. is a Research Assistant Professor in the Department of Pharmaceutics at the University of Florida. She is a practicing pharmacometrician with a background in Applied Mathematics. As an early-stage Principal Investigator, she is leading several funded computational modeling projects to create and innovate quantitative solutions in healthcare. The shared goal of these proejcts is to develop model-based clinical trial simulation tools, which will help drug developers optimize clinical trial designs.

She graduated summa cum laude with the President’s honor with a Bachelor’s degree in 2008, and completed her Master’s degree in 2010 both in Applied Mathematics from Hanyang University, South Korea. She earned her doctorate in Biomathematics at Florida State University in 2015. She has received several awards including David Goldstein and Presidential Trainee Awards from the American Society for Clinical Pharmacology and Therapeutics.

Accomplishments

Presidential Trainee Award
2018 · American Society for Clinical Pharmacology and Therapeutics
Peer Review Award for Pharmacology & Toxicology
2018 · Publons
Presidential Trainee Award
2017 · American Society for Clinical Pharmacology and Therapeutics
David Goldstein Trainee Award
2017 · American Society for Clinical Pharmacology and Therapeutics
Landahl Travel Grant
2015 · Society of Mathematical Biology
Scholarship
2012-2013 · Southern Scholarship Foundation
Pi Mu Epsilon Honor
2012 · National Pi Mu Epsilon Council
Poster Presentation Award
2009 · Korean Society for Mathematical Biology
Graduate Research Fellowship
2008-2010 · LG Corporation Yonam Foundation
Summa Cum Laude Graduation Honors
2008 · Hanyang University
Volunteer Corps Essay Contest Award
2007 · Hanyang University
Scholarship
2006-2007 · Beakwoon Scholarship Foundation
Full Tuition Scholarship
2004-2007 · Hanyang University

Research Profile

Dr. Kim’s current research focuses on:

(1) Mathematical modeling and simulations informing experimental designs to examine combinations of anti-Mycobacterium tuberculosis agents to identify optimal regimens which markedly shorten the length of tuberculosis treatments and prevent the emergence of resistance.

(2) Developing a disease progression model-based clinical trial simulation (CTS) tool designed to optimize clinical trial enrichment and design of studies to investigate the efficacy of potential therapies for Duchenne Muscular Dystrophy.

(3) Developing a disease progression model-based CTS tool designed to inform optimizing clinical trial designs for Type 1 Diabetes prevention studies.

Grants

Feb 2020 ACTIVE
A Model-based Clinical Trial Simulation Tool to Optimize Clinical Trial Designs for Type 1 Diabetes Prevention Studies
Role: Principal Investigator
Funding: JDRF
Jul 2019 ACTIVE
OoR Matching Support for CTSI
Role: Project Manager
Funding: UF DIV OF SPONSORED RES MATCHING FUNDS
Mar 2019 – Mar 2020
A Model-based Clinical Trial Simulation Tool to Optimize Clinical Trial Design of Studies to Investigate Efficacy of Potential Therapies for Duchenne Muscular Dystrophy
Role: Principal Investigator
Funding: CRITICAL PATH INSTITUTE

Education

Ph.D.
2015 · Florida State University
M.S.
2010 · Hanyang University
B.S.
2008 · Hanyang University

Contact Details

Phones:
Business:
(407) 313-7044
Emails: